(Total Views: 563)
Posted On: 06/04/2020 11:09:59 AM
Post# of 145254
I think it entirely depends on the strength of the data generated from the trials. If the data is statistically significant, but not overwhelming we will likely be required to do a Ph3 for M2M, and finish the Ph3 for Severe.
However, if the data is incontrovertible, I think we will get an approval of some sort.
However, if the data is incontrovertible, I think we will get an approval of some sort.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)